And a competitor nearer to home which is now listed on ASX - Fisher Paykel HealthCare (FPH) and also sells products into US markets. FPH also has a range of products not just ones focusing on sleep apnoea market so hence has a better potential all-around than a company just relying on one product (RMD)
Resmed, page-8
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.36 |
Change
0.550(1.49%) |
Mkt cap ! $23.66B | |||
| Open | High | Low | Value | Volume |
| $37.22 | $37.41 | $37.22 | $87.90M | 2.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $37.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.40 | 288 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| RMD (ASX) Chart |